Lipid microspheres incorporated by U937 cells via their specific receptors.
Lipid microspheres (LM), currently in clinical use as drug carriers, mainly consist of soybean oil as a core and lecithin as a surfactant. The purpose of our study wass to determine whether or not LM incorporation is receptor-mediated. U937 cells resuspended in a serum-free medium abundantly took up unmodulated LM. A binding study showed that U937 cells had a single binding site for LM (410 sites/cell at 24 degrees C; 100 sites/cell at 4 degrees C). Inhibition assays revealed that lecithin liposome, lysophosphatidylcholines, activated alpha2-macroglobulin, and HDL did not affect the binding of LM to U937 cells. VLDL strongly, and LDL and AcLDL moderately, inhibited the binding of LM to U937 cells. Ligand blotting analysis revealed that unmodulated LM in an apoprotein-free buffer directly bound to a 40 kDa protein in the cell membrane fraction. These results suggest that LM that is not modulated by any protein is incorporated by specific cells via receptor-mediated processes.
Suzuki
K
K
Internal Medicine I, National Defense Medical College, Tokorozawa, Saitama, Japan. kogen@me.ndmc.ac.jp
Hidaka
T
T
Shinohara
T
T
Kataharada
K
K
Okada
M
M
Takada
K
K
Ohsuzu
F
F
D001665:Binding Sites / Q000187:drug effects / Q000502:physiology; D001667:Binding, Competitive; D004337:Drug Carriers / Q000493:pharmacokinetics*; D006801:Humans; D008024:Ligands; D008055:Lipids / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000493:pharmacokinetics*; D008077:Lipoproteins, LDL / Q000378:metabolism / Q000494:pharmacology; D008079:Lipoproteins, VLDL / Q000378:metabolism / Q000494:pharmacology; D008863:Microspheres; D018110:Receptors, Lipoprotein / Q000378:metabolism*; D020298:U937 Cells / Q000378:metabolism*
D004337:Drug Carriers; D008024:Ligands; D008055:Lipids; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D018110:Receptors, Lipoprotein; C032629:acetyl-LDL